"La Mediterranea è una struttura ospedaliera e Centro Diagnostico, accreditati con il Servizio Sanitario Nazionale, che svolgono attività di alta specializzazione. L’ospedale dispone di 180 posti letto La Mediterranea è certificata in qualità a norma UNI EN ISO 9001/2008."

During the past decade, Clinica Mediterranea conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica Mediterranea" #1 sponsor was "Clinica Mediterranea" with 5 trials, followed by "Abbott Medical Devices" with 3 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "Daiichi Sankyo, Inc." with 2 trials sponsored and "National Cancer Institute, Naples" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Mediterranea" #1 collaborator was "Abbott Diagnostics Division" with 1 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator, "Alere, Inc." with 1 trials as a collaborator, "Cedars-Sinai Medical Center" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Clinica Mediterranea" are "Coronary Artery Disease" (4 trials), "Atrial Fibrillation" (3 trials), "Anemia" (2 trials), "Bleeding Disorder" (2 trials) and "Coagulation Disorder" (2 trials). Many other conditions were trialed in "Clinica Mediterranea" in a lesser frequency.

Most popular intervention types in "Clinica Mediterranea" are "Device" (12 trials), "Drug" (9 trials), "Behavioral" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "XIENCE" (2 trials), "Amphilimus Eluting Stent (CRE8)" (1 trials), "Bare metal stent implantation" (1 trials), "Basic physical activity" (1 trials) and "Bivalirudin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Mediterranea" are 22 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinica Mediterranea". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Clinica Mediterranea, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Mediterranea, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".

Clinica Mediterranea has several departments that took part in Clinical trials: "Clinica Mediterranea, U.O. Di Cardiologia" - 3 trials